×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
BiondVax hits branding reset to become Scinai Immunotherapeutics
Fierce Pharma
BiondVax is now Scinai Immunotherapeutics. While its roots were initially in the pursuit of a universal flu vaccine, the company has shifted its...
7 months ago
Press Release dated September 6, 2023, “BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd ...
SEC.gov
JERUSALEM, Sep. 6, 2023 (GLOBE NEWSWIRE) -- via IBN -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company, is pleased to...
7 months ago
BiondVax Pharmaceuticals Rebrands As Scinai Immunotherapeutics
Contract Pharma
BiondVax Pharmaceuticals Ltd., a biopharmaceutical company, has changed its corporate name to Scinai Immunotherapeutics Ltd. to reflect a new...
10 months ago
BiondVax signs exclusive license agreement
Max-Planck-Gesellschaft
BiondVax Pharmaceuticals has signed an exclusive worldwide license agreement to develop and commercialize VHH antibodies (NanoAbs) targeting...
10 months ago
New year, new name as Pipeline, Novozymes and Chr. Hansen rebranded to reflect new focus
Fierce Pharma
With a new year on the horizon, a clutch of companies have decided on new names for 2024. Pipeline Therapeutics has become Contineum...
4 months ago
BiondVax Announces Appointment of Amir Reichman as New CEO
PR Newswire
PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on development and manufacturing of...
39 months ago
BiondVax Announces Topline Results from Phase 3 Clinical Trial of the M-001 Universal Influenza Vaccine Candidate
BioSpace
JERUSALEM, Oct. 23, 2020 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a pioneer in the development of a universal flu...
42 months ago
The future of Medicine: Treatment for Diseases with Alpaca Antibodies
Haaretz
Scinai Immunotherapeutics Is Developing Drugs for Autoimmune and Infectious Diseases Using Nano-antibodies From Alpacas.
6 months ago
BiondVax bets on alpacas to treat psoriasis
Globes - Israel Business News
CEO Amir Reichman is striving to revive the company after the failure of its universal flu vaccination.
9 months ago
Ambitious plan sees Israel as heart of Middle East medical supply chain for US
The Times of Israel
US faith-based group leads 'near-shoring' Abraham Accords push to open regional FDA office with bipartisan support in Washington,...
17 months ago